Toxic Epidermal Necrolysis Associated with Antiepileptic Drugs and Cranial Radiation Therapy

Case reports on the development of toxic epidermal necrolysis (TEN) associated with concurrent administration of phenytoin with cranial radiation therapy (Ahmed (2004), Criton et al. (1997), and Rzany et al. (1996)), but reports about erythema multiforme, which can develop in patients treated with l...

Full description

Saved in:
Bibliographic Details
Main Authors: Shereen Elazzazy, Taghrid Abu Hassan, Ashraf El Seid, Cicy Mary Jacob
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2013/415031
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559962013827072
author Shereen Elazzazy
Taghrid Abu Hassan
Ashraf El Seid
Cicy Mary Jacob
author_facet Shereen Elazzazy
Taghrid Abu Hassan
Ashraf El Seid
Cicy Mary Jacob
author_sort Shereen Elazzazy
collection DOAJ
description Case reports on the development of toxic epidermal necrolysis (TEN) associated with concurrent administration of phenytoin with cranial radiation therapy (Ahmed (2004), Criton et al. (1997), and Rzany et al. (1996)), but reports about erythema multiforme, which can develop in patients treated with levetiracetam and cranial irradiation, are very limited. This paper presents evidence that TEN may be induced by concurrent use of radiation with both phenytoin and levetiracetam. Our case is a 42-year-old male patient, a case of gliosarcoma who developed purpuric dermatitis associated with phenytoin when combined with cranial radiation therapy; although phenytoin was discontinued and switched to levetiracetam, the patient had more severe symptoms of toxic epidermal necrolysis (TEN) on levetiracetam; the patient improved with aggressive symptom management, discontinuation of antiepileptic drugs (AEDs), and holding radiotherapy. Although TEN is a rare toxicity, physicians should pay a special attention to the monitoring of brain tumor patients on antiepileptic prophylaxis during cranial irradiation; furthermore, patients should be counselled to notify their physicians if they develop any new or unusual symptoms.
format Article
id doaj-art-41b49b2a079842e88bbef670b053866a
institution Kabale University
issn 2090-6706
2090-6714
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Case Reports in Oncological Medicine
spelling doaj-art-41b49b2a079842e88bbef670b053866a2025-02-03T01:28:39ZengWileyCase Reports in Oncological Medicine2090-67062090-67142013-01-01201310.1155/2013/415031415031Toxic Epidermal Necrolysis Associated with Antiepileptic Drugs and Cranial Radiation TherapyShereen Elazzazy0Taghrid Abu Hassan1Ashraf El Seid2Cicy Mary Jacob3Pharmacy Department, National Center for Cancer Care and Research NCCCR, Hamad Medical Corporation, Doha, QatarPharmacy Department, National Center for Cancer Care and Research NCCCR, Hamad Medical Corporation, Doha, QatarOncology Hematology Department, National Center for Cancer Care and Research NCCCR, Hamad Medical Corporation, Doha, QatarOncology Hematology Department, National Center for Cancer Care and Research NCCCR, Hamad Medical Corporation, Doha, QatarCase reports on the development of toxic epidermal necrolysis (TEN) associated with concurrent administration of phenytoin with cranial radiation therapy (Ahmed (2004), Criton et al. (1997), and Rzany et al. (1996)), but reports about erythema multiforme, which can develop in patients treated with levetiracetam and cranial irradiation, are very limited. This paper presents evidence that TEN may be induced by concurrent use of radiation with both phenytoin and levetiracetam. Our case is a 42-year-old male patient, a case of gliosarcoma who developed purpuric dermatitis associated with phenytoin when combined with cranial radiation therapy; although phenytoin was discontinued and switched to levetiracetam, the patient had more severe symptoms of toxic epidermal necrolysis (TEN) on levetiracetam; the patient improved with aggressive symptom management, discontinuation of antiepileptic drugs (AEDs), and holding radiotherapy. Although TEN is a rare toxicity, physicians should pay a special attention to the monitoring of brain tumor patients on antiepileptic prophylaxis during cranial irradiation; furthermore, patients should be counselled to notify their physicians if they develop any new or unusual symptoms.http://dx.doi.org/10.1155/2013/415031
spellingShingle Shereen Elazzazy
Taghrid Abu Hassan
Ashraf El Seid
Cicy Mary Jacob
Toxic Epidermal Necrolysis Associated with Antiepileptic Drugs and Cranial Radiation Therapy
Case Reports in Oncological Medicine
title Toxic Epidermal Necrolysis Associated with Antiepileptic Drugs and Cranial Radiation Therapy
title_full Toxic Epidermal Necrolysis Associated with Antiepileptic Drugs and Cranial Radiation Therapy
title_fullStr Toxic Epidermal Necrolysis Associated with Antiepileptic Drugs and Cranial Radiation Therapy
title_full_unstemmed Toxic Epidermal Necrolysis Associated with Antiepileptic Drugs and Cranial Radiation Therapy
title_short Toxic Epidermal Necrolysis Associated with Antiepileptic Drugs and Cranial Radiation Therapy
title_sort toxic epidermal necrolysis associated with antiepileptic drugs and cranial radiation therapy
url http://dx.doi.org/10.1155/2013/415031
work_keys_str_mv AT shereenelazzazy toxicepidermalnecrolysisassociatedwithantiepilepticdrugsandcranialradiationtherapy
AT taghridabuhassan toxicepidermalnecrolysisassociatedwithantiepilepticdrugsandcranialradiationtherapy
AT ashrafelseid toxicepidermalnecrolysisassociatedwithantiepilepticdrugsandcranialradiationtherapy
AT cicymaryjacob toxicepidermalnecrolysisassociatedwithantiepilepticdrugsandcranialradiationtherapy